17 March 2026
INHSU is excited to support the newly launched HERO in Practice initiative, the largest program in the United States focused on evaluating models of hepatitis C (HCV) care for people who inject drugs. HERO in Practice is being delivered as a partnership with the Coalition for Global Hepatitis Elimination (CGHE) and Prisma Health, building on proven, patient-centred approaches to screening, care and treatment for this priority population.
The project aims to reach more than 1,700 people who inject drugs across a range of care settings in six states, including community health centres and opioid treatment programs, to generate stronger evidence on how to deliver effective HCV services.
As part of this work, we will contribute our expertise in capacity building and implementation training. Across 2026 and 2027, INHSU will deliver a mix of virtual learning sessions and in-person HCV Intervention Symposia tailored to clinicians, program implementers and other stakeholders.
Drawing on our established U.S. HCV Intervention Symposia Series, these events typically include:
- A local needs assessment to identify priority service challenges and gaps
- Expert-led presentations on integrated and practical models of care
- Frontline case studies detailing real-world implementation lessons
- Peer learning and discussion to support shared problem-solving
- Updates on emerging evidence and best practice in testing, linkage to care and treatment
More information about INHSU’s HCV Intervention Symposia Program is available at:
https://inhsu.org/about-us/hepatitis-c-intervention-symposia-series-united-states/
These activities are all about helping teams put evidence into practice, strengthening the workforce and supporting the scale-up of equitable, high-quality HCV care models for people who inject drugs. This collaboration reflects our ongoing commitment at INHSU to improving hepatitis C service delivery, and it highlights just how important implementation training is in accelerating progress for the communities most affected by viral hepatitis.
